(19)
(11) EP 1 347 980 A1

(12)

(43) Date of publication:
01.10.2003 Bulletin 2003/40

(21) Application number: 01997029.2

(22) Date of filing: 30.11.2001
(51) International Patent Classification (IPC)7C07D 487/04, A61K 31/519, A61P 5/46, A61P 11/06
(86) International application number:
PCT/US0145/280
(87) International publication number:
WO 0205/7267 (25.07.2002 Gazette 2002/30)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 01.12.2000 US 728316
01.12.2000 US 728607
01.12.2000 US 728616

(71) Applicant: OSI Pharmaceuticals, Inc.
Melville, N.Y. 11747 (US)

(72) Inventors:
  • CASTELHANO, Arlindo, L.
    New City, New York 10579 (US)
  • MCKIBBEN, Bryan
    White Plains, NY 10605 (US)
  • WITTER, David, J.
    Putnam Valley, NY 10579 (US)

(74) Representative: VOSSIUS & PARTNER 
Siebertstrasse 4
81675 München
81675 München (DE)

   


(54) COMPOUNDS SPECIFIC TO ADENOSINE-A1,-A2A, AND- A3-RECEPTOR AND USES THEREOF